Levofloxacin pharmacokinetics in children

Journal of Clinical Pharmacology

Volumn 45, Issue 2, 2005, Pages 153-160

  Chien, Shuchean ^a   Wells, Thomas G ^b   Blumer, Jeffrey L ^c   Kearns, Gregory L ^d   Bradley, John S ^e   Bocchini Jr , Joseph A ^f   Natarajan, Jaya ^a   Maldonado, Samuel ^a   Noel, Gary J ^a,g  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e RADY CHILDREN'S HOSPITAL   (United States)

^f LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^g UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Levofloxacin; Pediatrics; Pharmacokinetics

Indexed keywords

LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SAFETY; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; MULTICENTER STUDY; PARAMETER; PATHOGENESIS; PROTEINURIA; SIDE EFFECT; STREPTOCOCCUS PNEUMONIAE; WOUND DEHISCENCE;

ADMINISTRATION, ORAL; ADOLESCENT; AGE FACTORS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; INPATIENTS; METABOLIC CLEARANCE RATE; OFLOXACIN;

EID: 16844364507     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270004271944     Document Type: Article

References (17)

1. Hurst M, Lamb HM, Scott LJ, Figgitt DP. Levofloxacin: an updated review of its use in the treatment of bacterial infections. Drugs. 2002; 62:2127-2167.
2. Fish DN, Chow AT. The clinical pharmacokinetics of levofloxacin. Clin Pharmacokinet. 1997;32:101-119.
3. Nightingale CH, Grant EM, Quintiliani R. Pharmacodynamics and pharmacokinetics of levofloxacin. Chemotherapy. 2000;46(suppl 1):6-14.
4. Burkhardt JE, Hill MA, Turek JJ, Carlton WW. Ultrastructural changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet Pathol. 1992;29:230-238.
5. Burkhardt JE, Walterspiel JN, Schaad UB. Quinolone arthropathy in animals versus children. Clin Infect Dis. 1997;25:1196-1204.
6. Alghasham AA, Nahata MC. Clinical use of fluoroquinolones in children. Ann Pharmacother. 2000;34:347-359.
7. Hanipel B, Hullmann R, Schmidt H. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use-safety report. Pediatr Infect Dis J. 1997;16:127-129.
8. Schaad UB, Salani MA, Aujard Y, et al. Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy Commission. Pediatr Infect Dis J. 1995;14:1-9.
9. Routledge PA. Pharmacokinetics in children. J. Antimicrob Chemother. 1994;34(suppl A):19-24.
10. San Joaquin VH, Stull TL. Antibacterial agents in pediatrics. Infect Dis Clin North Am. 2000;14:341-355.
11. Wong FA, Juzwin SJ, Flor SC. Rapid stereospecific high-performance liquid chromatographic determination of levofloxacin in human plasma and urine. J Pharm Biomed Anal. 1997;15:765-771.
12. Gibaldi M, Perrier D, eds. Pharmacokinetics. 2nd ed. New York: Marcel Dekker; 1982.
13. Chien S-C, Rogge MC, Gisclon LG, et al. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses. Antimicrob Agents Chemother. 1997;41:2256-2260.
14. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med. 2003; 349:1157-1167.
15. Levaquin tablets/injection (levofloxacin tablets/injection) prescribing information. Raritan, NJ: Ortho-McNeil Pharmaceutical; 2003.
16. Preston SL, Drusano GL, Berman AL, et al. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA. 1998; 279:125-129.
17. Schwartz GJ, Haycock GB, Edelmann CMJ, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58:259-263.